Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Mediolanum prepares novel quinolone antibacterial agents

Jan. 28, 1997

Spotlight on influenza sialidase inhibitors

Jan. 28, 1997

Roche presents new antifungal agents

Jan. 24, 1997

Antifungal echinocandin derivatives reported by Lilly

Jan. 24, 1997

MAb from Hayashibara with IFN-inducing properties

Jan. 23, 1997

Drug screening technology available for licensing

Jan. 22, 1997

n-Docosanol efficacy demonstrated in herpes labialis

Jan. 21, 1997

Shaman patents new antifungal agents

Jan. 21, 1997

Abbott isolates fusacandin antifungal agents

Jan. 20, 1997

Tularik, Merck & Co. extend R&D agreement

Jan. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.